Barclays lowered the firm’s price target on Chemours to $22 from $30 and keeps an Equal Weight rating on the shares post the Q2 report. The TiO2 market is relatively stable as the company’s refrigerant’s business operations was the negative surprise, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC: